Standout Papers

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a sin... 2019 2026 2021 2023 252
  1. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial (2019)
    Breelyn A. Wilky, Matteo Trucco et al. The Lancet Oncology

Immediate Impact

52 standout
Sub-graph 1 of 25

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
1 intermediate paper

Works of Mark K. Foley being referenced

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
2019 Standout

Author Peers

Author Last Decade Papers Cites
Mark K. Foley 25 21 42 217 203 17 430
Yuping Zhang 95 2 9 114 78 24 511
J.M. Malone 53 21 14 156 74 24 447
Marloes G. J. van Dongen 38 4 20 119 82 10 416
Anna Di Blasio 110 16 4 134 100 17 491
Krishna C. Penumatsa 14 11 9 191 50 18 412
Elaine Drobny 113 2 54 77 111 10 506
Derry Minyao Ng 55 1 16 97 96 24 416
Despina Mouratidou 41 11 5 114 222 21 429
V Deutsch 41 5 21 81 66 18 411
Varsha S. Jagtap 49 34 15 132 130 20 495

All Works

Loading papers...

Rankless by CCL
2026